Publication | Closed Access

Biodistribution and dosimetry results from a phase III prospectively randomized controlled trial of Zevalin™ radioimmunotherapy for low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma

Lymphoid NeoplasiaRadiation MedicineOncologyDosimetry ResultsRadiation TherapyZevalin™ RadioimmunotherapyPhase IiiHematologyClinical TrialsMedicineRadiation OncologyHealth Sciences